Bacteriophage Lysins in the Era of Antibiotic Resistance, 2nd Edition
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Bacteriophages".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 145
Special Issue Editor
Interests: bacteriophage; lysin; rapid microbial detection; African swine fever virus
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
On May 17, 2024, the World Health Organization updated its list of drug-resistant bacteria most threatening to human health, indicating that antimicrobial resistance is still a global challenge. Because of their rapid bactericidal activity and low chance for bacteria to generate resistance, bacteriophage lysins have been considered alternatives to traditional antibiotics. Since we organized the first Special Issue on bacteriophage lysins in 2021, many new developments have been achieved over the past 3 years. New lysins, especially lysins against Gram-negative bacteria, have been reported continuously. Some results from the clinical trial of lysins have been released. Now, it may be a good time to organize the second Special Issue on bacteriophage lysins to reflect the most recent advances in lysin research, both in preclinical and clinical settings.
We welcome contributions including, but not limited to, the following topics:
- The discovery of new lysins;
- Improvements in lysin properties, such as thermal stability, cell penetration, and activity;
- Synergy with other antimicrobials;
- Safety and the host’s immune response;
- Clinical trial design and results of lysin products;
- Other applications of lysins, such as in cosmetics and bacteria detection.
Prof. Dr. Hongping Wei
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lysin
- bacteriophage
- antibiotic resistance
- antimicrobial
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issue
- Bacteriophage Lysins in the Era of Antibiotic Resistance in Antibiotics (5 articles)
